Loading clinical trials...
Loading clinical trials...
Phase 1 safety, pharmacokinetics, and pharmacodynamics trial of the focal adhesion kinase (FAK) inhibitor PF-00562271 in patients with positive Positron Emission Tomography \[PET\] scans due to advanc...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Verastem, Inc.
NCT07542041 · Pancreatic Cancer, Pancreatic Neoplasms, and more
NCT06190899 · mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Diseases, Male, and more
NCT03937453 · Pancreatic Cancer, Pancreatic Neoplasms, and more
NCT07225946 · Prostatic Neoplasms, Castration-Resistant
NCT06051695 · Solid Tumor, Adult, Colorectal Cancer, and more
Pfizer Investigational Site
Aurora, Colorado
Pfizer Investigational Site
Nashville, Tennessee
Pfizer Investigational Site
East Melbourne, Victoria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions